![Kenneth Kelley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Kelley
Amministratore Delegato presso
IDBiologics, Inc.
Profilo
Kenneth J. Kelley è un uomo d'affari che ha fondato IntraBiotics Pharmaceuticals, Inc. e Emergent Travel Health, Inc. e che è stato a capo di 7 diverse aziende. Attualmente ricopre la posizione di presidente di Seromyx Systems, Inc. e di presidente di Selva Therapeutics, Inc. Kelley fa anche parte del consiglio di amministrazione di Halozyme Therapeutics, Inc. (ex presidente), Meissa Vaccines, Inc., Actym Therapeutics, Inc. e IDBiologics, Inc. e amministratore delegato di K2 BioVentures LLC. Nella sua carriera passata Kenneth J. Kelley è stato direttore di Solus Biosystems, Inc., presidente di Fluxion Biosciences, Inc., socio generale di Latterell Venture Partners, socio di Institutional Venture Partners, consulente di McKinsey & Co., Inc., presidente e amministratore delegato di IntraBiotics Pharmaceuticals, Inc., direttore di Emergent Travel Health, Inc. e scienziato di Integrated Genetics, Inc. Kenneth J. Kelley si è laureato alla Harvard University e ha conseguito un MBA alla Stanford University.
Posizioni attive di Kenneth Kelley
| Società | Posizione | Inizio |
|---|---|---|
K2 BioVentures LLC | Corporate Officer/Principal | 07/07/2010 |
Meissa Vaccines, Inc.
 Meissa Vaccines, Inc. BiotechnologyHealth Technology Develops vaccines for respiratory syncytial virus and rhinovirus | Direttore/Membro del Consiglio | 27/03/2019 |
Actym Therapeutics, Inc.
 Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune-oncology therapies | Direttore/Membro del Consiglio | - |
IDBiologics, Inc.
 IDBiologics, Inc. BiotechnologyHealth Technology Develops human monoclonal antibodies for the prevention, treatment and cure of infectious diseases | Amministratore Delegato | 01/01/2017 |
Seromyx Systems, Inc.
 Seromyx Systems, Inc. Pharmaceuticals: MajorHealth Technology Develop immune vaccines, immunotherapies, drugs and diagnostics | Presidente | - |
Selva Therapeutics, Inc.
 Selva Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company dedicated to development of therapeutics for infectious diseases | Presidente | - |
Precedenti posizioni note di Kenneth Kelley
| Società | Posizione | Fine |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Presidente | 01/01/2015 |
Latterell Venture Partners
 Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners invests in companies located in the United States. The firm focuses on biotechnology, research instrument, biomaterial, medical device and diagnostic ventures, pharmaceutical sectors. It provides financing for early stage capital requirements with an investment size of USD 0.05 - 10 million. It makes co-investments and also acts as a lead investor. It takes seat on the board of directors. | Corporate Officer/Principal | 01/06/2004 |
Albert B. Sabin Vaccine Institute, Inc.
 Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Creates solutions to health threats | Direttore/Membro del Consiglio | - |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Kenneth Kelley
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
51
Relazioni di 1° grado
19
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 19 |
|---|---|
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Latterell Venture Partners
Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners invests in companies located in the United States. The firm focuses on biotechnology, research instrument, biomaterial, medical device and diagnostic ventures, pharmaceutical sectors. It provides financing for early stage capital requirements with an investment size of USD 0.05 - 10 million. It makes co-investments and also acts as a lead investor. It takes seat on the board of directors. | Finance |
Solus Biosystems, Inc.
 Solus Biosystems, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops tools for measurement of changes in protein conformation | Electronic Technology |
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Creates solutions to health threats | Commercial Services |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Health Technology |
Fluxion Biosciences, Inc.
 Fluxion Biosciences, Inc. Information Technology ServicesTechnology Services Provides automated patch clamp technology and cell-based assay tools | Technology Services |
Institutional Venture Partners
 Institutional Venture Partners Investment ManagersFinance Institutional Venture Partners invests in companies located in North America and Europe. The firm focuses on a broad range of sectors. It provides financing for growth stage capital requirements with the investment size of USD 15 - 75 millions. It also participates in follow on investments. | Finance |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MPEX Pharmaceuticals, Inc.
 MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapies for antibiotic resistance | Commercial Services |
Integrated Genetics, Inc.
 Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations | Health Technology |
K2 BioVentures LLC | |
Meissa Vaccines, Inc.
Meissa Vaccines, Inc. BiotechnologyHealth Technology Develops vaccines for respiratory syncytial virus and rhinovirus | Health Technology |
Actym Therapeutics, Inc.
Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune-oncology therapies | Health Technology |
Seromyx Systems, Inc.
Seromyx Systems, Inc. Pharmaceuticals: MajorHealth Technology Develop immune vaccines, immunotherapies, drugs and diagnostics | Health Technology |
IDBiologics, Inc.
IDBiologics, Inc. BiotechnologyHealth Technology Develops human monoclonal antibodies for the prevention, treatment and cure of infectious diseases | Health Technology |
Selva Therapeutics, Inc.
Selva Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company dedicated to development of therapeutics for infectious diseases | Health Technology |
